Entering text into the input field will update the search result below

Biodel reports FQ3 results

  • Biodel (BIOD) FQ3 results: Revenues: $0; R&D Expense: $5.1M (+41.7%); SG&A: $1.5M (+15.4%); Net Loss: ($6.5M) (-103.1%); Loss Per Share: ($0.12) (+20.0%); Quick Assets: $44.4M (+80.5%).
  • No guidance given.

Recommended For You

Related Stocks

SymbolLast Price% Chg
ALBO--
Albireo Pharma, Inc.